Choose language
Do you want to set the chosen language as default?
Yes, set as default
Search
Trending Topics
Stock

Meta

 Stock

Google

 Asset

ETFs

 Crypto

Crypto

 Stock

Nvidia

 Stock

Chevron

Stocks

See all

ETFs

See all

Cryptocurrencies

See all

Tools

Price

$ 11.85

return (12m)

232.87% Logo

p/e

-1.10

p/bv

1.19

DIVIDEND YIELD

0.00%
graph

KZIA price

KZIA
If you had invested
If you had invested
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*The figure considers the reinvestment of dividends.

Return on Investment KZIA

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
65.50%
3 months
80.64%
1 year
232.87%
2 years
-35.95%
5 years
-97.79%
10 years
-97.28%
Estatistica

Fundamentals KZIA

review the fundamentals of Kazia Therapeutics shares

P/E

-1.10
Sector: -4.04 Industry: -4.04

P/S (PSR)

23.58
Sector: -3.86 Industry: -3.86

P/BV

1.19
Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%
Sector: - Industry: -

ROA

-71.01%
Sector: -61.23% Industry: -61.23%

ROE

-108.65%
Sector: -60.44% Industry: -60.44%

ROIC

-260.41%
Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

-100.00%
Sector: -39.16% Industry: -39.16%

GROSS MARGIN

100.00%
Sector: 37.91% Industry: 37.91%

OPERATING MARGIN

-100.00%
Sector: -39.32% Industry: -39.32%

EV/EBITDA

-1.23
Sector: -3.92 Industry: -3.92

EV/EBIT

-1.18
Sector: -4.14 Industry: -4.14

PRICE-TO-ASSETS

0.78
Sector: 1.41 Industry: 1.41

BVPS

10.29
Sector: 1.88 Industry: 1.88

EPS

-11.18
Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

0.65
Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.35
Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

3,688.08%
Sector: - Industry: -

CAGR PROFIT 5 YEARS

2,581.49%
Sector: - Industry: -
statistics

Fundamentals KZIA

Buy And Hold Investor Checklist

Kazia Therapeutics Buy And Hold Investor Checklist


This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]

Stock Comparison Tool

graph

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.
Price

KZIA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

ABOUT

Logo Kazia Therapeutics

Kazia Therapeutics Limited

Average Investor10 user rating

4.0 (0 people)

United States

United States

32 years

Founded: 1994

Time since IPO - - year

-

Employees

Market cap

$ 36.78 Millions

$ 36.78 Millions

Net worth

$ 30.88 Millions

$ 30,880,000.00

Assets

$ 47.25 Millions

$ 47,250,000.00

Total Shares Outstanding

3.00 Millions

3,000,000

Average Daily Trading Volume

$ 213.23 Thousand

$ 213,228.00

Sector

Health Care

Industry

Biotechnology

Shares

KZIA
receitas e lucros

KZIA revenue and profits

graph

PROFIT X PRICE KZIA

resultados

Financial Results KZIA

DRAG THE FRAME TO SEE MORE DATA
Resultados

KZIA cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - KZIA

Pontos Relevantes

KZIA balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more stocks
Logo Biofrontera

BFRA - Biofrontera

$ - -0,00% (12M)
P/E

0.00

DY

0.00%

ROE

-893.55%

P/BV

0.00
Logo McKesson

MCK - McKesson

$ 835.00 18,64% (12M)
P/E

23.47

DY

0.38%

ROE

-4,383.84%

P/BV

-1,028.86
Logo Cardinal Health

CAH - Cardinal Health

$ 205.61 48,69% (12M)
P/E

28.38

DY

1.02%

ROE

-61.56%

P/BV

-17.47
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$ 227.79 51,06% (12M)
P/E

26.05

DY

2.29%

ROE

25.92%

P/BV

6.75
Logo Pfizer

PFE - Pfizer

$ 26.48 21,32% (12M)
P/E

19.76

DY

6.37%

ROE

8.35%

P/BV

1.65
Logo AbbVie

ABBV - AbbVie

$ 197.69 6,38% (12M)
P/E

83.09

DY

3.35%

ROE

0.00%

P/BV

0.00
Logo Merck & Co.

MRK - Merck & Co.

$ 110.03 34,61% (12M)
P/E

15.22

DY

2.97%

ROE

0.00%

P/BV

0.00
Logo AstraZeneca

AZN - AstraZeneca

$ 186.68 32,34% (12M)
P/E

28.78

DY

1.69%

ROE

20.99%

P/BV

6.04
Logo Biofrontera

BFRA - Biofrontera

$ - -0,00% (12 M)
P/L

0.00

DY

0.00%

ROE

-893.55%

P/VP

0.00
Logo McKesson

MCK - McKesson

$ 835.00 18,64% (12 M)
P/L

23.47

DY

0.38%

ROE

-4,383.84%

P/VP

-1,028.86
Logo Cardinal Health

CAH - Cardinal Health

$ 205.61 48,69% (12 M)
P/L

28.38

DY

1.02%

ROE

-61.56%

P/VP

-17.47
Logo Johnson & Johnson

JNJ - Johnson & Johnson

$ 227.79 51,06% (12 M)
P/L

26.05

DY

2.29%

ROE

25.92%

P/VP

6.75
Logo Pfizer

PFE - Pfizer

$ 26.48 21,32% (12 M)
P/L

19.76

DY

6.37%

ROE

8.35%

P/VP

1.65
Logo AbbVie

ABBV - AbbVie

$ 197.69 6,38% (12 M)
P/L

83.09

DY

3.35%

ROE

0.00%

P/VP

0.00
Logo Merck & Co.

MRK - Merck & Co.

$ 110.03 34,61% (12 M)
P/L

15.22

DY

2.97%

ROE

0.00%

P/VP

0.00
Logo AstraZeneca

AZN - AstraZeneca

$ 186.68 32,34% (12 M)
P/L

28.78

DY

1.69%

ROE

20.99%

P/VP

6.04

Frequently Asked Questions

What is the price of Kazia Therapeutics (KZIA) today?

The current price of Kazia Therapeutics (KZIA) is $ 11.85, representing a 232.87% gain over the past year. The stock began the year trading around $ 6.89 and is currently priced at $ 11.85. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Kazia Therapeutics (KZIA) pay dividends?

Kazia Therapeutics (KZIA) did not pay dividends over the past year.

Is Kazia Therapeutics (KZIA) a good investment?

Kazia Therapeutics (KZIA) is currently trading at $ 11.85 with a P/E ratio of -1.10%. This represents a -25,002,274% premium compared to its historical average P/E. Over the past year, the stock has gained 232.87 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 232.87%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kazia Therapeutics (KZIA) stock?

You can buy Kazia Therapeutics (KZIA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KZIA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Kazia Therapeutics (KZIA) yield today?

Over the past month, Kazia Therapeutics (KZIA) has returned 65.50% — 232.87% over the past year, and -97.79% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Kazia Therapeutics (KZIA) today at the current price of $ 11.85 your total investment would be $ 1,185.00.

Based on historical performance, the investment would have grown to approximately:

  • $ 3,944.51 after 1 year
  • $ 26.19 after 5 years
  • $ 32.23 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.